GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Retained Earnings

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Retained Earnings : ¥1,632 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Hubei Hongyuan Pharmaceutical Technology Co's retained earnings for the quarter that ended in Mar. 2024 was ¥1,632 Mil.

Hubei Hongyuan Pharmaceutical Technology Co's quarterly retained earnings declined from Sep. 2023 (¥1,619 Mil) to Dec. 2023 (¥1,601 Mil) but then increased from Dec. 2023 (¥1,601 Mil) to Mar. 2024 (¥1,632 Mil).

Hubei Hongyuan Pharmaceutical Technology Co's annual retained earnings increased from Dec. 2021 (¥1,166 Mil) to Dec. 2022 (¥1,563 Mil) and increased from Dec. 2022 (¥1,563 Mil) to Dec. 2023 (¥1,601 Mil).


Hubei Hongyuan Pharmaceutical Technology Co Retained Earnings Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Retained Earnings Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 488.74 721.79 1,166.20 1,562.68 1,600.98

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
Jun15 Dec15 Jun16 Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,627.31 1,587.59 1,618.87 1,600.98 1,632.18

Hubei Hongyuan Pharmaceutical Technology Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Hubei Hongyuan Pharmaceutical Technology Co  (SZSE:301246) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600
Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines